{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:48:05Z","timestamp":1794674885123,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13012-016-0420-8","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T04:37:53Z","timestamp":1461127073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Finding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in Vietnam"],"prefix":"10.1186","volume":"11","author":[{"given":"Vivian F.","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana J.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tuyet","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross C.","family":"Brownson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Viet","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"420_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2105\/AJPH.93.8.1261","volume":"93","author":"RE Glasgow","year":"2003","unstructured":"Glasgow RE, Lichtenstein E, Marcus AC. Why don\u2019t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93:1261\u20137.","journal-title":"Am J Public Health."},{"key":"420_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2105\/AJPH.2012.300755","volume":"102","author":"RE Glasgow","year":"2012","unstructured":"Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102:1274\u201381.","journal-title":"Am J Public Health."},{"key":"420_CR3","doi-asserted-by":"crossref","unstructured":"Grimshaw J, Eccles M, Thomas R, MacLennan, Ramsay C, Fraser C, et al. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966\u20131998. J Gen Intern Med. 2006;21(Suppl 2):S14-20.","DOI":"10.1007\/s11606-006-0269-7"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-7-50","volume":"7","author":"JM Grimshaw","year":"2012","unstructured":"Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012;7:50.","journal-title":"Implement Sci."},{"key":"420_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13012-015-0216-2","volume":"10","author":"SM Kegeles","year":"2015","unstructured":"Kegeles SM, Rebchook G, Tebbetts S, Arnold E. Facilitators and barriers to effective scale-up of an evidence-based multilevel HIV prevention intervention. Implement Sci. 2015;10:50.","journal-title":"Implement Sci."},{"issue":"Suppl 1","key":"420_CR6","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/QAI.0b013e3182920286","volume":"63","author":"RE Glasgow","year":"2013","unstructured":"Glasgow RE, Eckstein ET, Elzarrad MK. Implementation science perspectives and opportunities for HIV\/AIDS research: integrating science, practice, and policy. J Acquir Immune Defic Syndr. 2013;63 Suppl 1:S26\u201331.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"420_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/QAI.0b013e31820bb448","volume":"56","author":"NS Padian","year":"2011","unstructured":"Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President\u2019s Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56:199\u2013203.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"Suppl 1","key":"420_CR8","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/QAI.0b013e3181f9c1da","volume":"55","author":"BR Schackman","year":"2010","unstructured":"Schackman BR. Implementation science for the prevention and treatment of HIV\/AIDS. J Acquir Immune Defic Syndr. 2010;55 Suppl 1:S27\u201331.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"420_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s10461-011-9913-2","volume":"15","author":"JL Heitgerd","year":"2011","unstructured":"Heitgerd JL, Kalayil EJ, Patel-Larson A, Uhl G, Williams WO, Griffin T, et al. Reduced sexual risk behaviors among people living with HIV: results from the Healthy Relationships Outcome Monitoring Project. AIDS Behav. 2011;15:1677\u201390.","journal-title":"AIDS Behav."},{"key":"420_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2105\/AJPH.2008.140657","volume":"100","author":"JB Jemmott","year":"2010","unstructured":"Jemmott JB, Jemmott LS, Fong GT, Morales KH. Effectiveness of an HIV\/STD risk-reduction intervention for adolescents when implemented by community-based organizations: a cluster-randomized controlled trial. Am J Public Health. 2010;100:720\u20136.","journal-title":"Am J Public Health."},{"issue":"2","key":"420_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/OLQ.0b013e3181f0c051","volume":"38","author":"MS Neumann","year":"2011","unstructured":"Neumann MS, O'Donnell L, Doval AS, Schillinger J, Blank S, Ortiz-Rios E, et al. Effectiveness of the VOICES\/VOCES sexually transmitted disease\/human immunodeficiency virus prevention intervention when administered by health department staff: does it work in the \u201creal world\u201d? Sex Transm Dis. 2011;38(2):133\u20139.","journal-title":"Sex Transm Dis"},{"issue":"3\u20134","key":"420_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10464-014-9629-3","volume":"53","author":"MB Feldman","year":"2014","unstructured":"Feldman MB, Silapaswan A, Schaefer N, Schermele D. Is there life after DEBI? Examining health behavior maintenance in the diffusion of effective behavioral interventions initiative. Am J Community Psychol. 2014;53(3\u20134):286\u2013313.","journal-title":"Am J Community Psychol"},{"key":"420_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-2-42","volume":"2","author":"AM Kilbourne","year":"2007","unstructured":"Kilbourne AM, Neumann MS, Pincus HA, Bauer MS, Stall R. Implementing evidence-based interventions in health care: application of the replicating effective programs framework. Implement Sci. 2007;2:42.","journal-title":"Implement Sci."},{"key":"420_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1748-5908-9-39","volume":"9","author":"TJ Waltz","year":"2014","unstructured":"Waltz TJ, Powell BJ, Chinman MJ, Smith JL, Matthieu MM, Proctor EK, et al. Expert recommendations for implementing change (ERIC): protocol for a mixed methods study. Implement Sci. 2014;9:39.","journal-title":"Implement Sci."},{"key":"420_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1077558711430690","volume":"69","author":"BJ Powell","year":"2012","unstructured":"Powell BJ, McMillen JC, Proctor EK, Carpenter CR, Griffey RT, Bunger AC, et al. A compilation of strategies for implementing clinical innovations in health and mental health. Med Care Res Rev. 2012;69:123\u201357.","journal-title":"Med Care Res Rev."},{"key":"420_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21.","journal-title":"Implement Sci."},{"key":"420_CR17","unstructured":"Cochrane Effective Practice and Organisation of Care (EPOC) Group. EPOC Taxonomy of professional and organisational interventions. 2002. http:\/\/epoc.cochrane.org\/epoc-taxonomy . Accessed 2 May 2015."},{"key":"420_CR18","doi-asserted-by":"crossref","unstructured":"Mazza D, Bairstow P, Buchan H, Chakraborty SP, Van Hecke O, Grech C, et al. Refining a taxonomy for guideline implementation: results of an exercise in abstract classification. Implement Sci. 2013;8:32.","DOI":"10.1186\/1748-5908-8-32"},{"key":"420_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci."},{"key":"420_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/0272989X08326146","volume":"28","author":"B Spring","year":"2008","unstructured":"Spring B. Health decision making: lynchpin of evidence-based practice. Med Decis Mak. 2008;28:866\u201374.","journal-title":"Med Decis Mak."},{"key":"420_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10488-010-0302-3","volume":"39","author":"GA Aarons","year":"2012","unstructured":"Aarons GA, Cafri G, Lugo L, Sawitzky A. Expanding the domains of attitudes towards evidence-based practice: the evidence based attitudes scale-50. Adm Policy Ment Health Ment Health Serv Res. 2012;39:331\u201340.","journal-title":"Adm Policy Ment Health Ment Health Serv Res."},{"issue":"4","key":"420_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1077558708317802","volume":"65","author":"BJ Weiner","year":"2008","unstructured":"Weiner BJ, Amick H, Lee SY. Conceptualization and measurement of organizational readiness for change: a review of the literature in health services research and other fields. Med Care Res Rev. 2008;65(4):379\u2013436.","journal-title":"Med Care Res Rev"},{"key":"420_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaac.2012.01.018","volume":"51","author":"GA Aarons","year":"2012","unstructured":"Aarons GA, Sommerfeld DH. Leadership, innovation climate, and attitudes toward evidence-based practice during a statewide implementation. J Am Acad Child Adolesc Psychiatry. 2012;51:423\u201331.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"420_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-5908-3-26","volume":"3","author":"R Raghavan","year":"2008","unstructured":"Raghavan R, Bright CL, Shadoin AL. Toward a policy ecology of implementation of evidence-based practices in public mental health settings. Implement Sci. 2008;3:26.","journal-title":"Implement Sci."},{"issue":"1","key":"420_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1468-1293.2003.00130.x","volume":"4","author":"S Clarke","year":"2003","unstructured":"Clarke S, Delamere S, McCullough L, Hopkins S, Bergin C, Mulcahy F. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med. 2003;4(1):33\u20137.","journal-title":"HIV Med"},{"issue":"2\u20133","key":"420_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3109\/10826084.2011.522840","volume":"46","author":"CO Cunningham","year":"2011","unstructured":"Cunningham CO, Sohler NL, Cooperman NA, Berg KM, Litwin AH, Arnsten JH. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse. 2011;46(2\u20133):218\u201332.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"420_CR27","first-page":"492","volume":"108","author":"PA Selwyn","year":"1993","unstructured":"Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of on-site primary care services by HIV seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep. 1993;108(4):492\u2013500.","journal-title":"Public Health Rep"},{"issue":"Suppl 5","key":"420_CR28","doi-asserted-by":"publisher","first-page":"S402","DOI":"10.1086\/421404","volume":"38","author":"B Conway","year":"2004","unstructured":"Conway B, Prasad J, Reynolds R, Farley J, Jones M, Jutha S, et al. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis. 2004;38 Suppl 5:S402\u20138.","journal-title":"Clin Infect Dis."},{"issue":"9","key":"420_CR29","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/cid\/cir537","volume":"53","author":"KM Berg","year":"2011","unstructured":"Berg KM, Litwin AH, Li X, Heo M, Arnsten JH. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention. Clin Infect Dis. 2011;53(9):936\u201343.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"420_CR30","doi-asserted-by":"publisher","first-page":"S409","DOI":"10.1086\/421405","volume":"38","author":"GM Lucas","year":"2004","unstructured":"Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis. 2004;38 Suppl 5:S409\u201313.","journal-title":"Clin Infect Dis."},{"issue":"11","key":"420_CR31","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1086\/503905","volume":"42","author":"GM Lucas","year":"2006","unstructured":"Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis. 2006;42(11):1628\u201335.","journal-title":"Clin Infect Dis"},{"issue":"1\u20133","key":"420_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.07.025","volume":"120","author":"S Nahvi","year":"2012","unstructured":"Nahvi S, Litwin AH, Heo M, Berg KM, Li X, Arnsten JH. Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Drug Alcohol Depend. 2012;120(1\u20133):174\u201380.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"420_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jsat.2012.08.014","volume":"43","author":"JL Sorensen","year":"2012","unstructured":"Sorensen JL, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, et al. Directly administered antiretroviral therapy: Pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012;43(4):418\u201323.","journal-title":"J Subst Abuse Treat"},{"key":"420_CR34","doi-asserted-by":"crossref","unstructured":"Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161:85\u201391.","DOI":"10.1001\/archinte.161.1.85"},{"key":"420_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/00002030-199905280-00012","volume":"13","author":"FL Altice","year":"1999","unstructured":"Altice FL, Friedland GH, Cooney EL. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS. 1999;13:957\u201362.","journal-title":"AIDS."},{"key":"420_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00007691-200110000-00010","volume":"23","author":"PA Bart","year":"2001","unstructured":"Bart PA, Rizzardi PG, Gallant S, et al. Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir. Ther Drug Monit. 2001;23:553\u20135.","journal-title":"Ther Drug Monit."},{"key":"420_CR37","first-page":"2510","volume":"12","author":"P Beauverie","year":"1998","unstructured":"Beauverie P, Taburet AM, Dessalles MC, Furlan V, Touzeau D. Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors. AIDS. 1998;12:2510\u20131.","journal-title":"AIDS."},{"key":"420_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1086\/339541","volume":"34","author":"S Clarke","year":"2002","unstructured":"Clarke S, Mulcahy F, Bergin C, et al. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir. Clin Infect Dis. 2002;34:1143\u20135.","journal-title":"Clin Infect Dis."},{"key":"420_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1086\/322519","volume":"33","author":"SM Clarke","year":"2001","unstructured":"Clarke SM, Mulcahy FM, Tjia J, et al. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis. 2001;33:1595\u20137.","journal-title":"Clin Infect Dis."},{"key":"420_CR40","doi-asserted-by":"crossref","unstructured":"Clarke SM, Mulcahy FM, Tjia J, et al. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol. 2001;51:213\u201317.","DOI":"10.1046\/j.1365-2125.2001.00342.x"},{"key":"420_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00042560-200106010-00010","volume":"27","author":"JG Gerber","year":"2001","unstructured":"Gerber JG, Rosenkranz S, Segal Y, et al. Effect of ritonavir\/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401. J Acquir Immune Defic Syndr. 2001;27:153\u201360.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"420_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1176\/appi.ajp.157.3.481","volume":"157","author":"EF McCance-Katz","year":"2000","unstructured":"McCance-Katz EF, Farber S, Selwyn PA, O'Connor A. Decrease in methodone levels with nelfinavir mesylate. Am J Psychiatry. 2000;157:481.","journal-title":"Am J Psychiatry."},{"key":"420_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1086\/376907","volume":"37","author":"EF McCance-Katz","year":"2003","unstructured":"McCance-Katz EF, Rainey PM, Friedland G, Jatlow P. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis. 2003;37:476\u201382.","journal-title":"Clin Infect Dis."},{"key":"420_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0091270003262956","volume":"44","author":"MJ Shelton","year":"2004","unstructured":"Shelton MJ, Cloen D, DiFrancesco R, et al. The effects of once-daily saquinavir\/minidose ritonavir on the pharmacokinetics of methadone. J Clin Pharmacol. 2004;44:293\u2013304.","journal-title":"J Clin Pharmacol."},{"key":"420_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/00126334-200308150-00016","volume":"33","author":"RC Stevens","year":"2003","unstructured":"Stevens RC, Rapaport S, Maroldo-Connelly L, Patterson JB, Bertz R. Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir\/ritonavir. J Acquir Immune Defic Syndr. 2003;33:650\u20131.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"420_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/B:AIBE.0000030250.33931.af","volume":"8","author":"BR Crisp","year":"2004","unstructured":"Crisp BR, Williams M, Timpson S, Ross MW. Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS Behav. 2004;8(2):199\u2013206.","journal-title":"AIDS Behav"},{"issue":"4","key":"420_CR47","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.qai.0000186392.26334.e3","volume":"41","author":"A Knowlton","year":"2006","unstructured":"Knowlton A, Arnsten J, Eldred L, Wilkinson J, Gourevitch M, Shade S, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006;41(4):486\u201392.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"420_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/apc.2005.19.31","volume":"19","author":"JT Parsons","year":"2005","unstructured":"Parsons JT, Rosof E, Punzalan JC, Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV positive men and women: results of a pilot project. AIDS Patient Care STDS. 2005;19(1):31\u20139.","journal-title":"AIDS Patient Care STDS"},{"key":"420_CR49","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1086\/500200","volume":"42","author":"S Basu","year":"2006","unstructured":"Basu S, Smith-Rohrberg D, Bruce RD, Altice FL. Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis. 2006;42:716\u201321.","journal-title":"Clin Infect Dis."},{"issue":"4","key":"420_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.drugpo.2007.03.001","volume":"18","author":"L Sylla","year":"2007","unstructured":"Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV\/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18(4):306\u201312.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"420_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000423","volume":"8","author":"SS Alistar","year":"2011","unstructured":"Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med. 2011;8(3):1\u201315.","journal-title":"PLoS Med"},{"issue":"3","key":"420_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.drugalcdep.2012.02.021","volume":"125","author":"BX Tran","year":"2012","unstructured":"Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam\u2019s injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125(3):260\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"420_CR53","first-page":"1","volume":"61","author":"US Department of Health and Human Services","year":"2012","unstructured":"US Department of Health and Human Services. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the US Department of Health and Human Services. MMWR Recomm Rep. 2012;61:1\u201340.","journal-title":"MMWR Recomm Rep"},{"key":"420_CR54","unstructured":"World Health Organization. 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/download\/en\/ . Accessed 2 May 2015."},{"key":"420_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","volume":"376","author":"D Wolfe","year":"2010","unstructured":"Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355\u201366.","journal-title":"Lancet."},{"key":"420_CR56","unstructured":"Joint United Nations Programme on HIV\/AIDS. Gap report 2014. 2014. http:\/\/www.unaids.org\/en\/resources\/documents\/2014\/20140716_UNAIDS_gap_report . Accessed 2 May 2015."},{"issue":"Suppl 4","key":"420_CR57","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.1086\/522557","volume":"45","author":"DD Celentano","year":"2007","unstructured":"Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis. 2007;45 Suppl 4:S318\u201323.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"420_CR58","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","volume":"103","author":"M Malta","year":"2008","unstructured":"Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242\u201357.","journal-title":"Addiction"},{"key":"420_CR59","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/cid\/cit427","volume":"57","author":"JP Meyer","year":"2013","unstructured":"Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57:1309\u201317.","journal-title":"Clin Infect Dis."},{"issue":"5","key":"420_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","volume":"105","author":"S Uhlmann","year":"2010","unstructured":"Uhlmann S, Milloy MJ, Kerr T, Zhang R, Guillemi S, Marsh D, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907\u201313.","journal-title":"Addiction"},{"issue":"7","key":"420_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1468-1293.2009.00701.x","volume":"10","author":"R Weber","year":"2009","unstructured":"Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, et al. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med. 2009;10(7):407\u201316.","journal-title":"HIV Med"},{"issue":"8","key":"420_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/01.aids.0000168982.20456.eb","volume":"19","author":"E Wood","year":"2005","unstructured":"Wood E, Hogg RS, Kerr T, Palepu A, Zhang R, Montaner JS. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. AIDS. 2005;19(8):837\u20139.","journal-title":"AIDS"},{"issue":"6","key":"420_CR63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jama.280.6.567","volume":"280","author":"R Sherer","year":"1998","unstructured":"Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA. 1998;280(6):567\u20138.","journal-title":"JAMA"},{"issue":"2","key":"420_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00002030-200001280-00010","volume":"14","author":"JP Moatti","year":"2000","unstructured":"Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000;14(2):151\u20135.","journal-title":"AIDS"},{"issue":"4","key":"420_CR65","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.drugpo.2006.12.014","volume":"18","author":"B Spire","year":"2007","unstructured":"Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18(4):262\u201370.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"420_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1525-1497.2003.20122.x","volume":"18","author":"BJ Turner","year":"2003","unstructured":"Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248\u201357.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"420_CR67","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1080\/09540120701351888","volume":"19","author":"PL Hicks","year":"2007","unstructured":"Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134\u201340.","journal-title":"AIDS Care"},{"issue":"2","key":"420_CR68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","volume":"84","author":"A Palepu","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188\u201394.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"420_CR69","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","volume":"103","author":"P Roux","year":"2008","unstructured":"Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction. 2008;103(11):1828\u201336.","journal-title":"Addiction"},{"issue":"9","key":"420_CR70","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1086\/630209","volume":"49","author":"P Roux","year":"2009","unstructured":"Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009;49(9):1433\u201340.","journal-title":"Clin Infect Dis"},{"key":"420_CR71","first-page":"93","volume":"91","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z. Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China. WHO Bull. 2013;91:93\u2013101.","journal-title":"WHO Bull."},{"key":"420_CR72","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/apc.2008.0260","volume":"23","author":"F Lombard","year":"2009","unstructured":"Lombard F, Proescholdbell RJ, Cooper K, Musselwhite L, Quinlivan EB. Adaptations across clinical sites of an integrated treatment model for persons with HIV and substance abuse. AIDS Patient Care STDs. 2009;23:631\u20138.","journal-title":"AIDS Patient Care STDs."},{"issue":"Suppl 1","key":"420_CR73","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.drugalcdep.2013.07.033","volume":"132","author":"AA Boltaev","year":"2013","unstructured":"Boltaev AA, El-Bassel N, Deryabina AP, Terlikbaeva A, Gilbert L, Hunt T, et al. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward. Drug Alcohol Depend. 2013;132 Suppl 1:S41\u20137.","journal-title":"Drug Alcohol Depend."},{"key":"420_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/541489","volume":"2012","author":"TF Kresina","year":"2012","unstructured":"Kresina TF, Lubran R, Clark HW, Cheever LW. Substance abuse treatment, HIV\/AIDS, and the continuum of response for people who inject drugs. Advances in Preventive Medicine. 2012;2012:1\u20138.","journal-title":"Advances in Preventive Medicine."},{"key":"420_CR75","volume-title":"Report on integrated treatment for HIV-infected opioid dependent persons","author":"RD Bruce","year":"2010","unstructured":"Bruce RD. Report on integrated treatment for HIV-infected opioid dependent persons. USAID: Ukraine; 2010."},{"issue":"1","key":"420_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2013.09.005","volume":"25","author":"RD Bruce","year":"2014","unstructured":"Bruce RD, Lambdin B, Chang O, Masao F, Mbwambo J, Mteza I, et al. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25(1):22\u20135.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"420_CR77","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.drugpo.2014.04.021","volume":"25","author":"C Lin","year":"2014","unstructured":"Lin C, Cao X, Li L. Integrating antiretroviral therapy in methadone maintenance therapy clinics: service provider perceptions. Int J Drug Policy. 2014;25(6):1066\u201370.","journal-title":"Int J Drug Policy"},{"key":"420_CR78","volume-title":"Vietnam AIDS response progress report 2014: following up the 2011 political declaration on HIV and AIDS (reporting period: January 2012-December 2013)","author":"Ministry of Health of Vietnam","year":"2014","unstructured":"Ministry of Health of Vietnam. Vietnam AIDS response progress report 2014: following up the 2011 political declaration on HIV and AIDS (reporting period: January 2012-December 2013). Hanoi: Ministry of Health of Vietnam; 2014."},{"key":"420_CR79","unstructured":"Vietnam Administration for HIV\/AIDS Control, personal communication, January 20, 2015"},{"key":"420_CR80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1748-5908-8-105","volume":"8","author":"EK Proctor","year":"2013","unstructured":"Proctor EK, Landsverk J, Baumann AA, Mittman BS, Aarons GA, Brownson RC, Glisson C, Chambers D. The implementation research institute: training mental health implementation researchers in the United States. Implement Sci. 2013;8:105.","journal-title":"Implement Sci."}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-016-0420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13012-016-0420-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-016-0420-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-016-0420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:47:39Z","timestamp":1567792059000},"score":1,"resource":{"primary":{"URL":"http:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-016-0420-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1186\/s13012-016-0420-8","relation":{},"ISSN":["1748-5908"],"issn-type":[{"value":"1748-5908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"54"}}